Unigestion Holding’s Thermo Fisher Scientific TMO Stock Holding History

Unigestion Holding’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,972	Closed	-$3M	–	199
2023 Q3	$3M	Sell	5,972 -330	-5%	-$176K	0.18%	81
2023 Q2	$3.24M	Buy	6,302 +4,781	+314%	+$2.58M	0.19%	82
2023 Q1	$856K	Sell	1,521 -480	-24%	-$271K	0.05%	151
2022 Q4	$1.11M	Sell	2,001 -4,080	-67%	-$2.16M	0.06%	146
2022 Q3	$3.14M	Buy	6,081 +517	+9%	+$289K	0.18%	88
2022 Q2	$3.02M	Sell	5,564 -256	-4%	-$141K	0.17%	83
2022 Q1	$3.44M	Buy	5,820 +3,304	+131%	+$1.9M	0.15%	77
2021 Q4	$1.68M	Buy	2,516 +2,033	+421%	+$1.27M	0.07%	104
2021 Q3	$280K	Sell	483 -1,687	-78%	-$926K	0.01%	179
2021 Q2	$1.1M	Sell	2,170 -991	-31%	-$468K	0.04%	149
2021 Q1	$1.44M	Buy	3,161 +997	+46%	+$476K	0.05%	128
2020 Q4	$1.01M	Buy	+2,164	New	+$1.01M	0.03%	133
2019 Q1	–	Sell	-7,767	Closed	-$1.74M	–	301
2018 Q4	$1.74M	Hold	7,767	–	–	0.04%	194
2018 Q3	$1.9M	Buy	+7,767	New	+$1.79M	0.04%	225

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Unigestion Holding's TMO Position: Q4 2023 in Review

Unigestion Holding sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 5,972 shares — an estimated $3M sold.

Unigestion Holding first reported a position in TMO in Q3 2018 and held it in 14 quarters. The position peaked at $3.44M in Q1 2022. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

Unigestion Holding reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
Unigestion Holding sold 5,972 Thermo Fisher Scientific shares in Q4 2023, an estimated $3M.
Unigestion Holding first reported a position in Thermo Fisher Scientific in Q3 2018 and held it in 14 quarters.
Unigestion Holding's Thermo Fisher Scientific position peaked at $3.44M in Q1 2022.
2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Unigestion Holding's 13F filing for Q4 2023, filed 14 Feb 2024.